E-LIB Suche - Ergebnisse für: Luigi Zinzani, Pier

1

CHRONOS-4: Phase 3 study of copanlisib plus rituximab-based..:

Zinzani, Pier Luigi Luigi ; Wang, Huaqing ; Feng, Jifeng...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

2

P1070: DECISIONAL ROLE OF INTERIM PET IN RELAPSED/REFRACTOR..:

Rusconi, Chiara ; Ricci, Francesca ; Daffini, Rosa...
HemaSphere. 7 (2023) S3 - p. e95482eb , 2023

Link: https://doi.org/10.1097/..

3

P1068: UPDATED RESULTS FROM AN OPEN-LABEL PHASE 1/2 STUDY O..:

Timmerman, John ; Lavie, David ; Johnson, Nathalie...
HemaSphere. 7 (2023) S3 - p. e5990067 , 2023

Link: https://doi.org/10.1097/..

4

P1141: ENCOURAGING COMPLETE RESPONSES (CRS) OBSERVED WITH C..:

Shortt, Jake ; Feldman, Tatyana ; Collins, Graham...
HemaSphere. 7 (2023) S3 - p. e41693c0 , 2023

Link: https://doi.org/10.1097/..

5

P1067: ESTIMATING THE RELATIVE EFFICACY OF FAVEZELIMAB WHEN..:

Armand, Philippe ; Luigi Zinzani, Pier ; Timmerman, John...
HemaSphere. 7 (2023) S3 - p. e8856772 , 2023

Link: https://doi.org/10.1097/..

6

P1084: LONG-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB (ZANU)..:

Opat, Stephen ; Tedeschi, Alessandra ; Hu, Bei...
HemaSphere. 7 (2023) S3 - p. e77003b0 , 2023

Link: https://doi.org/10.1097/..

7

P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPD..:

Caimi, Paolo F ; Ai, Weiyun Z ; Pablo Alderuccio, Juan...
HemaSphere. 7 (2023) S3 - p. e402511c , 2023

Link: https://doi.org/10.1097/..

8

P1124: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIP..:

Mehta-Shah, Neha ; Jacobsen, Eric ; Luigi Zinzani, Pier...
HemaSphere. 7 (2023) S3 - p. e3891642 , 2023

Link: https://doi.org/10.1097/..

9

P1081: A MULTICENTER OBSERVATIONAL STUDY ON CHIMERIC ANTIGE..:

Chiappella, Annalisa ; Dodero, Anna ; Ljevar, Silva...
HemaSphere. 7 (2023) S3 - p. e8573795 , 2023

Link: https://doi.org/10.1097/..

10

P1080: ZANUBRUTINIB PLUS OBINUTUZUMAB VERSUS OBINUTUZUMAB I..:

Trotman, Judith ; Luigi Zinzani, Pier ; Mayer, Jiri...
HemaSphere. 7 (2023) S3 - p. e2687131 , 2023

Link: https://doi.org/10.1097/..

11

P1087: PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR PRE-TREATED ..:

Jurczak, Wojciech ; Luigi Zinzani, Pier ; Eyre, Toby A....
HemaSphere. 7 (2023) S3 - p. e45636b5 , 2023

Link: https://doi.org/10.1097/..

12

P1142: AFM13 IN PATIENTS WITH R/R PERIPHERAL T CELL LYMPHOM..:

Kim, Won-Seog ; Shortt, Jake ; Luigi Zinzani, Pier...
HemaSphere. 7 (2023) S3 - p. e6843062 , 2023

Link: https://doi.org/10.1097/..

13

ABCL-135: RE-MIND: A Comparison of Tafasitamab (MOR208) + L..:

Rodgers, Thomas ; Luigi Zinzani, Pier ; Marino, Dario...
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) - p. S265-S266 , 2020

Link: https://doi.org/10.1016/..

14

Long‐term analysis of phase II studies of single‐agent lena..:

Witzig, Thomas E. ; Luigi Zinzani, Pier ; Habermann, Thomas M....
American Journal of Hematology. 92 (2017) 10 - p. , 2017

Link: https://doi.org/10.1002/..

15

Non-Hodgkin's lymphoma: the evolving role of purine analogu..:

Luigi Zinzani, Pier
Best Practice & Research Clinical Haematology. 15 (2002) 3 - p. 505-516 , 2002

Link: https://doi.org/10.1053/..